Company attributes
Industry
B2X
Founder
Legal Name
ProstaGene, LLC
Legal classification
Number of Employees (Ranges)
11 – 50
Full Address
901 NORTH PENN STREET, APT R1902, PHILADELPHIA, PA, 19123
CIK Number
Total Funding Amount (USD)
2,225,000
Latest Funding Round Date
April 2016
Former CEO
Latest Funding Type
Other attributes
Company Operating Status
Closed
ProstaGene is a biotechnology company that develops technology that is based on patents of Dr. Richard G. Pestell. It combines molecular diagnostics with therapeutic screening and commercial experience, for developing novel treatments for cancer.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
